Examples of such forward-looking statements include but are not limited to express or implied statements regarding TuHURA's expectations, hopes, beliefs, intentions or strategies regarding the ...

Come out to support the Wake Tech Social Sciences Club students as they share their original content analysis research in a poster showcase. Pop in between 11 a.m. and 12 p.m. to mingle, offer ...

United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at the International Society for Heart and Lung ...

"We are thrilled that our research involving our selective degrader programs for SMARCA2, CDK2 and IKZF2 will be showcased prominently at AACR 2025, including during two oral presentations ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

Cogent also announced today that the Compensation Committee of Cogent’s Board of Directors, made up entirely of independent directors, approved the grant of an “inducement” equity award on ...

Erasca will also present potential first-in-class examples of direct SMP complex ... today announced the company will present three poster presentations at the upcoming American Association ...

today announced that an abstract detailing a potential predictive biomarker for THIO treatment was selected for poster presentation at the European Lung Cancer Congress 2025 (ELCC 2025 ...

Erasca will also present potential first-in-class examples of direct SMP complex inhibitors ... today announced the company will present three poster presentations at the upcoming American Association ...

Tempest Therapeutics is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the ...